Evidence map›Paper›PMID 31231123›Full record

ArticleBone marrow transplantation2020

XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT.

Giuseppe Visani, Federica Loscocco, Irene Bagaloni, Annamaria Ruzzo, Fabio Fuligni, Francesco Graziano, Mauro Magnani, Alessandro Isidori

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Giuseppe Visani *Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Pesaro, Italy. giuseppe.visani@ospedalimarchenord.it.
Federica Loscocco *Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Pesaro, Italy.
Irene BagaloniDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Annamaria RuzzoDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Fabio FuligniGenetics and Genome Biology, Paediatric Laboratory Medicine (PLM), The Hospital for Sick Children, Toronto, Canada.
Francesco GrazianoOncology, Marche Nord Hospital, Pesaro, Italy.
Mauro MagnaniDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Alessandro Isidori *Hematology and Stem Cell Transplant Center, Marche Nord Hospital, Pesaro, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LymphomaAntineoplastic Combined Chemotherapy ProtocolsGenotypeHumansTransplantation, AutologousX-ray Repair Cross Complementing Protein 1X-ray Repair Cross Complementing Protein 1XRCC1 protein, human

Identifiers

PMID31231123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.